KALKOFEN DONALD A. (Chief Financial Officer) received a stock award from PROTAGONIST THERAPEUTICS, INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/26/2021ACC: 0001209191-21-014973
Officer· Chief Financial Officer
Since May 2019
+62.50K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
62.50K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+7.50K
Price / share
—
Trade value
—
% of position
259.9%
2/26/2021
2.89K→10.39K
Total
Net shares
+7.50K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/26/2021 | A · Award | +7.50K | — | — | 259.9% | 2.89K | 10.39K |
| Total | +7.50K | $0.00 | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
55K shares
Shares
+55K
Strike price
23.57
Held after
55K
Exercisable
—
2/26/2021
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock55K shares | 2/26/2021 | A · Award | +55K | 23.57 | — | 55K |